These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 265185)

  • 1. Clearance of phenylalanine ammonia-lyase from normal and tumor-bearing mice.
    Shen RS; Fritz RR; Abell CW
    Cancer Res; 1977 Apr; 37(4):1051-6. PubMed ID: 265185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical properties and immunogenicity of L-phenylalanine ammonia-lyase: effects on tumor-bearing mice.
    Shen RS; Fritz RR; Abell CW
    Cancer Treat Rep; 1979 Jun; 63(6):1063-8. PubMed ID: 466645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total-body radiation suppression of the clearance of phenylalanine ammonia-lyase from mouse plasma.
    Shen RS; Jenkins VK; Fritz RR; Briner RP; Abell CW
    J Reticuloendothel Soc; 1978 Mar; 23(3):167-75. PubMed ID: 650637
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo effects of phenylalanine ammonia-lyase.
    Roberts J; Schmid FA; Takai K
    Cancer Treat Rep; 1976 Mar; 60(3):261-3. PubMed ID: 1260781
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylalanine ammonia-lyase. Induction and purification from yeast and clearance in mammals.
    Fritz RR; Hodgins DS; Abell CW
    J Biol Chem; 1976 Aug; 251(15):4646-50. PubMed ID: 985816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
    J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on growth of B-16 melanoma.
    Meadows GG; DiGiovanni J; Minor L; Elmer GW
    Cancer Res; 1976 Jan; 36(1):167-71. PubMed ID: 1247996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase.
    Abell CW; Hodgins DS; Stith WJ
    Cancer Res; 1973 Oct; 33(10):2529-32. PubMed ID: 4517735
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
    Pierson HF; Meadows GG
    J Natl Cancer Inst; 1985 Sep; 75(3):507-16. PubMed ID: 3861901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
    Safos S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):681-92. PubMed ID: 8556141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN; Gámez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
    Pearlstein E; Ambrogio C; Karpatkin S
    Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria.
    Ikeda K; Schiltz E; Fujii T; Takahashi M; Mitsui K; Kodera Y; Matsushima A; Inada Y; Schulz GE; Nishimura H
    Amino Acids; 2005 Nov; 29(3):283-7. PubMed ID: 15977040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of IgE from serum of normal and hybridoma-bearing mice.
    Haba S; Ovary Z; Nisonoff A
    J Immunol; 1985 May; 134(5):3291-7. PubMed ID: 3980994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.